Report Overview
[ 170 + Pages Research Report ] Infectious Disease Diagnostics Market to surpass USD 50.1 billion by 2031 from USD 25.6 billion in 2021 at a CAGR of 6.9% in the coming years, i.e., 2021-2031.
Product Overview
Infectious illness diagnosis is a diagnostic method that uses a variety of diagnostic tools to detect the presence of foreign antigens or organisms, and it is carried out by trained technicians or physicians. Various diagnosis procedures and devices are used to evaluate a sample of blood, urine, mucus, or other body fluids in order to offer information on the causative organism. The epidemiological burden of infectious diseases such as SARS, Middle East respiratory syndrome (MERS), chikungunya, Ebola, avian flu, Zika, and swine flu has paved the way for early detection and prevention.
Market Highlights
Global Infectious Disease Diagnostics Market is expected to project a notable CAGR of 6.9% in 2031.
The market is being driven by factors such as the global prevalence of infectious diseases and rising awareness for early disease identification, a shift in focus from centralized laboratories to decentralized point-of-care testing, and technical breakthroughs. In addition, rising demand for point-of-care diagnostic tests and an increase in the prevalence of infectious diseases such as hepatitis, influenza, COVID-19, and human immunodeficiency virus (HIV) are driving market expansion.
Global Infectious Disease Diagnostics Market: Segments
The Assays & Reagents segment is expected to grow with the highest CAGR during 2021-31
Based on Product, the global Infectious Disease Diagnostics Market is fragmented into Assays & Reagents, Instruments, and Software. Due to the rising number of R&D activities in the pharmaceutical & biotechnology industry, increased demand for reagents, and increased use of point-of-care testing, the assays & reagents segment led the market in previous years, and this trend is expected to continue over the estimated period. However, due to an increase in the number of research laboratories and increased funding by government and private organizations for the development of diagnostic equipment, the instruments segment is projected to grow considerably throughout the forecast period.
The Others segment is expected to grow with the highest CAGR during 2021-31
Global Infectious Disease Diagnostics Market is classified on the basis of Technology into Immunodiagnostics, Clinical Microbiology, Polymerase Chain Reaction, Next Generation Sequencing, and Others. Due to a large number of key players offering advanced diagnostic medical devices, increased demand for DNA analysis, development of novel & innovative PCR tools, and advancement in R&D activities for infectious disease diagnosis, the others segment dominated the market in 2020, and this trend is expected to continue during the forecast period.
Market Dynamics
Drivers
The Growing Prevalence of Infectious Diseases across the globe
Infectious disease prevalence in both developed and developing nations will boost the infectious disease diagnostics market's growth. The growing number of prescriptions for contagious diseases diagnostic tests is because of the diagnosis and management of such illnesses. During the projection period, these factors, combined with the growing tendency toward preventive care, are projected to increase the demand for infectious disease diagnostics.
Increasing Geriatric Population that is prone to Infectious Diseases to drive the market
The rise in the geriatric population promotes market growth since older people are more susceptible to infectious diseases. Additionally, rising public awareness of the importance of early diagnosis and management of infectious diseases, as well as an increase in the number of information technology systems used to develop advanced diagnostic devices, are expected to provide lucrative opportunities for the global infectious disease diagnostic market to grow during the forecast period.
Restraint
Unfavorable Reimbursement Policies
Inadequate reimbursement is a major stumbling block to the infectious disease diagnostics market. Most diagnostic companies have a significant barrier in commercializing their tests: convincing health insurers to pay for them.
Global Infectious Disease Diagnostics Market: Key Players
- Abbott Laboratories
- Becton Dickinson and Company
- bioMerieus SA
- Bio-Rad Laboratories
- Danaher Corporation
- F Hoffman-La Roche
- Hologic Inc.
- Luminex Corporation
- Qiagen Inc.
- Thermo Fisher Scientific Inc.
- Other Prominent Players
Global Infectious Disease Diagnostics Market: Regions
Global Infectious Disease Diagnostics Market is segmented based on regional analysis into five major regions: North America, Latin America, Europe, Asia Pacific and the Middle East and Africa. In the year 2021, North America held the highest proportion of the global infectious illness diagnostics market. The high burden of infections, rising healthcare expenditure, implementation of favorable government initiatives, improved healthcare infrastructures, and easy access to technologically advanced instruments are all factors driving the growth of the infectious disease diagnostics market in North America.
Impact of COVID-19 on Infectious Disease Diagnostics Market
Government organizations around the world are assisting laboratories in expediting COVID-19 testing methods since testing remains a critical step in preventing the disease's rapid spread. The COVID-19 pandemic had a negative influence on most companies' overall sales, but it had a favorable impact on the infectious illness diagnostics industry since infectious disease diagnostic procedures were used for COVID-19 testing.
Global Infectious Disease Diagnostics Market is further segmented by region into:
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Russia, and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, Japan, and Rest of Asia Pacific
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, South Africa, and Rest of Middle East and Africa
Global Infectious Disease Diagnostics Market report also contains analysis on:
Infectious Disease Diagnostics Market Segments:
- By Product
- Assays & Reagents
- Instruments
- Software
- By Disease Type
- Hepatitis
- Human Immunodeficiency Virus
- Influenza
- Others
- By Technology
- Immunodiagnostics
- Clinical Microbiology
- Polymerase Chain Reaction
- Next Generation Sequencing
- Others
- Infectious Disease Diagnostics Market Dynamics
- Infectious Disease Diagnostics Market Size
- Supply & Demand
- Current Trends/Issues/Challenges
- Competition & Companies Involved in the Market
- Value Chain of the Market
- Market Drivers and Restraints
Infectious Disease Diagnostics Market Report Scope and Segmentation
| Report Attribute | Details |
| Market size value in 2021 | USD 25.6 billion |
| Revenue forecast in 2031 | USD 50.1 billion |
| Growth Rate | CAGR of 6.9% from 2021 to 2031 |
| Base year for estimation | 2020 |
| Quantitative units | Revenue in USD million and CAGR from 2021 to 2031 |
| Report coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments covered | Product, Disease Type, Technology, and Region |
| Regional scope | North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA) |
| Key companies profiled | Abbott Laboratories, Becton Dickinson and Company, bioMerieus SA, Bio-Rad Laboratories, Danaher Corporation, F Hoffman-La Roche, Hologic Inc., Luminex Corporation, Qiagen Inc., Thermo Fisher Scientific Inc., and Other Prominent Players. |
Frequently Asked Questions (FAQ):
Infectious Disease Diagnostics Market size was estimated at USD 25.6 billion in 2021 and is expected to reach USD 50.1 billion in 2031.
The diagnosis of infectious illnesses is labeled as a laboratory test used to diagnose the diseases with the help of skilled physicians and technicians.
The Assays & Reagents segment accounted for the largest Infectious Disease Diagnostics Market share.
Key players in the Infectious Disease Diagnostics Market include Abbott Laboratories, Becton Dickinson and Company, bioMerieus SA, Bio-Rad Laboratories, Danaher Corporation, F Hoffman-La Roche, Hologic Inc., Luminex Corporation, Qiagen Inc., Thermo Fisher Scientific Inc., and Other Prominent Players.
Infectious disease prevalence is predicted to rise, as is demand for point-of-care diagnostic tests, funding from private and government organisations for diagnostic service centres, and technological improvements in the field of infectious disease diagnostics.
.png){kind=icon}
